The Sangamo Domain
Vital Information for Sangamo Therapeutics (SGMO) Investors
Monday, June 29, 2015
Dr. Ando presenting in Edinburgh Scotland at Controlled Release 2015
Abstract 81
81
Creation of human TNFR1-selective antagonistic TNF mutants using phage display to develop novel anti-inflammatory biodrugs
http://www.controlledreleasesociety.org/meetings/annual/abstracts/Pages/2015Abstracts.aspx
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment